Glycopeptide Resistance in Staphylococcus aureus
- 31 May 2000
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 40 (3) , 211-217
- https://doi.org/10.1053/jinf.2000.0651
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf areaJournal of Antimicrobial Chemotherapy, 1999
- Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycinThe Lancet, 1999
- Historical Yearly Usage of VancomycinAntimicrobial Agents and Chemotherapy, 1998
- First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospitalThe Lancet, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Supplementary report by the Working Party on antibiotic sensitivity testing of the British Society for Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 1996
- Current perspectives on glycopeptide resistanceClinical Microbiology Reviews, 1995
- Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalisNCTC 12201 toStaphylococcus aureusFEMS Microbiology Letters, 1992
- High-level vancomycin-resistant enterococci causing hospital infectionsEpidemiology and Infection, 1989